RCMT
RCMCNasdaq / Commercial & Professional Services
Last Price
At close
2026-07-18
Current thesis
RCM still shows resilient profitability and a healthier mix in Specialty Healthcare, with the Q1 print demonstrating earnings durability despite Engineering weakness. The packet’s $31 median analyst target implies roughly 40% upside from the $22.18 anchor if execution and controls stabilize.
Posture
Mixed
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.5.
What can break
Auditor transition from EisnerAmper to Withum increases governance scrutiny until remediation is demonstrated.
Momentum
76
Value
58
Sentiment
33
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $24.00 · Bull $31.00 · Bear $18.00
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-20 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-20 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-18
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $38.00
Why
Momentum76 · Δ7d -12.1
Value58 · Δ7d +0.5
Sentiment33 · Δ7d -1.4
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Value · See fundamentals
Momentum
76
26% active weight
Current posture
7d trendFlat
Δ7d
-12.1
Δ21d
+3.9
Value
58
39% active weight
Current posture
7d trendFlat
Δ7d
+0.5
Δ21d
+1.0
Sentiment
33
34% active weight
Current posture
7d trendSoftening
Δ7d
-1.4
Δ21d
+0.5
Why this grade
Composite grade C. Momentum 75.9 / Value 58.4 / Sentiment 32.6
Fundamentals (TTM)As of 2026-07-20
Fundamentals (TTM)
As of 2026-07-20
Market Cap
$196.54M
Beta
-0.03
Shares Out
7.09M
P/E (TTM)
11.7
P/S (TTM)
0.48
P/FCF (TTM)
42.41
Rev YoY
-1.7%
EPS YoY
-4.1%
Gross Margin
+27.0%
Op Margin
+7.0%
Net Debt
$28M
Current Ratio
1.92
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology